Call Girls Doddaballapur Road Just Call 7001305949 Top Class Call Girl Servic...
Â
Short stature
1. Short & Tall Stature
Dr Kaushik Barot
Assistant Professor ,Pediatrics
2. SHORT STATURE: DEFINITION
⢠Height less than 3rd percentile or 2 SDs of the normal
for age, sex and reference population.
⢠Height velocity less than 25th percentile for age, sex
and reference population.
⢠Height < 1.5 SD of MPH/outside MPH range.
2
4. FAMILIAL SHORT STATURE
⢠MPH < 3rd percentile for
reference population
⢠Normal tempo of puberty
⢠Normal height velocity
⢠CA=BA>HA
⢠Final height is < 3rd centile
for reference population
but within target range
5. CONSTITUTIONAL DELAY IN
GROWTH AND PUBERTY
⢠Normal MPH
⢠Family h/o delayed
puberty but not always.
⢠BA=HA<CA
⢠Normal height velocity
⢠Delayed puberty
⢠Normal final height
6. CLUES FOR PATHOLOGICAL SHORT STATURE
⢠Height less then -3 SD
⢠Disproportionate SS
⢠Dysmorphism
⢠Height velocity less then 25 centile
⢠BMI increased or decreased
⢠Marked delay in bone age
⢠Major systemic manifestations
7. DISPROPORTIONATE SHORT STATURE
Short limbs (Increased US/LS)
⢠Achondroplasia
⢠Hypochondroplasia
⢠Pseudoachondroplasia
⢠Hypothyroidism
⢠Rickets
⢠Osteogenesis imperfecta
⢠Chondrodysplasia punctata
⢠Multiple epiphyseal
dysplasia
⢠Mesomelic dysplasia
⢠Acrodysostosis
Short trunk (Decreased US/LS)
⢠Spondyloepiphyseal
dysplasia
⢠Spondylometaphyseal
dysplasia
⢠Mucopolysachcharidoses
⢠Mucolipidoses
⢠Pots spine
⢠Alagille syndrome
Skeletal survey should be done to rule out skeletal
dysplasia in patients with disproportionate short
stature
8.
9. ACHONDROPLASIA
Autosomal dominant (FGFR3 gene)
⢠Macrocephaly
⢠Short limbs (proximal shortening)
⢠Trident hands
⢠Bowing of legs (varus deformity)
⢠Obesity
⢠Neurological anomalies
⢠Champagne glass pelvis on xray
⢠Spinal lordosis
⢠foramen magnum stenosis
13. MALNUTRITION
⢠Chronic malnutrition can give rise to stunting. W/H reduced more.
⢠Most common cause of pathological short stature in developing
countries.
⢠Delayed puberty.
⢠Iron, Calcium, Vitamin D & Zinc deficiency can cause short stature.
⢠IGF â 1 is diminished in under nutrition. GH levels may be low, normal
or high. The biochemical picture is suggestive of a form of GH
resistance.
14. IUGR (PRIMORDIAL DWARF)
⢠Arrest of fetal growth in early embryonic life. Reduced number of
cells and diminished growth potential
⢠20-30% donât show catchup growth & achieve there genetic
potential.
⢠Height is < 3 SD
⢠Growth velocity-altered
⢠Bone age-normal
26. DRUGS CAUSING SHORT STATURE
⢠Glucocorticoids
⢠Sex steroids
⢠Dextroamphetamines
⢠Metheylphenidate
27. POINTERS FROM HISTORY ASSOCIATED DISEASES
⢠Birth size (length, weight,
head circumference) and
gestational age
⢠Birth history (breech
delivery, asphyxia, jaundice,
hypoglycaemia)
⢠Parental height
⢠Tempo of puberty in parents
⢠Family history
⢠Previous growth
information
⢠Social environment
⢠To identify small for gestational
age (symmetric vs asymmetric)
⢠Associated with pituitary
dysfunction
⢠To assess genetic potential to
grow
⢠To look for family h/o delayed
puberty
⢠To look for a genetic cause
⢠May provide clues about the
aetiology
⢠To look for emotional
deprivation
HISTORY AND EXAMINATION
30. CLINICAL POINTERS ASSOCIATED DISEASES
⢠Round facies, facial
plethora, virillization
⢠Pharyngeal examination
⢠Bradycardia, dry skin,
goitre
⢠Hypertension
⢠Hepatosplenomegaly
⢠Pubertal stage
⢠Micropenis
⢠Fundoscopy, visual field
defect
⢠Signs of neglect or abuse
⢠Cushingâs syndrome
⢠Look for adenotonsillar hypertrophy
⢠Hypothyroidism
⢠Kidney disease, Cushingâs syndrome
⢠Hepatic, haematological or metabolic
disorder
⢠Early, normal or late puberty
⢠Hypogonadism, hypopituitarism
⢠Central nervous system pathology
⢠Emotional deprivation
31. Short stature*
Detailed medical history and physical examination
SHORT LIMB DWARFISM
US:LS increases
Proportionate short stature
Height velocity-NORMAL
PHYSIOLOGICAL
Disproportionate short stature
SHORT TRUNK DWARFISM
US:LS decreased
Height velocity-REDUCED
PATHOLOGICAL
BONE AGE/ SMR
Family History
Mid Parental height
MIXED
BA = CA
SMR=normal
Short parents
FAMILIAN SHORT STATURE
BA=CA<HA
BA < CA by 2-3 years
SMR delayed
F/H of CDGP
CDGP
BA=HA<CA
DYSMORPHISM
Genetic syndromes
NON-DYSMORPHIC
CONGENITAL ACQUIRED
⢠IUGR
⢠Genetic
syndromes
Check Height Velocity
32. Proportionate Short Stature ,non dysmorphic
ACQUIRED
OBESITY
BA < CA by 3 years or more
W/A<H/A
Weight is more affected
BA=HA<CA
BA>CA by 3 years or more
ENDOCRINE CAUSES
⢠Precocious puberty
⢠CAH
⢠Hyperthyroidism
W/A > H/A
Weight is less affected or may
be more
WORKUP
Level1,2,3 as needed
IDIOPATHIC
Extreme short stature
Level 1,2,3 IX normal
No cause found
MALNUTRITION
PSCHOSOCIAL
DWARFISM
CHRONIC INFECTIONS
ENDOCRINE CAUSES
ď§ Hypothyroidism
ď§ Growth hormone deficiency
ď§ Growth hormone insensitivity
ď§ Hypoparathyroidism
ď§ Cushingâs syndrome
SYSTEMIC CAUSES
BONE AGE
Weight or Height is more
affected ?
33. WHEN TO EVALUATE?
⢠Severe short stature (height SDS <-3 SD).
⢠Severe growth deceleration (height velocity SDS <-2
SD over 12 months).
⢠Height <-2 SD and height velocity <-1.0 SD over 12
months.
⢠Height <-1.5 SD and height velocity <-1.5 SD over 2
years.
⢠Risk factors for GHD.
34. INVESTIGATIONS : STEP 1
⢠CBC, ESR
⢠RFT/LFT
⢠Chest X-ray
⢠X-ray Left hand and wrist-AP
⢠Serum electrolytes
⢠Serum calcium, phosphorous, alkaline phosphatase
⢠Urine analysis including urine pH
⢠Stool for parasites, fat globules and occult blood
⢠Tuberculosis workup if suspected
35. INVESTIGATIONS: STEP 2
⢠FT4/TSH
⢠FSH and Karyotyping (in girls)
⢠Arterial blood gas
⢠Serum Tissue transglutaminase IgA type
⢠LDDST (only if clinical suspicion)
36. INVESTIGATIONS: STEP 3
TO RULE OUT GROWTH HORMONE RELATED
DISORDERS
⢠IGF-1 and IGFBP3
⢠Growth hormone stimulation tests
⢠MRI pituitary
37.
38. SHOX GENE MUTATION
⢠SHOX - SHort stature homeobOX
⢠Mild body disproportion
⢠Ranges from mild to severe form-Leri-Weill dyschondrosteosis
⢠LWS is triad of short stature, mesomelia, and Madelung deformity.
⢠SHOX mutation also associated with short phenotype in Turner's
syndrome.
39. CLINICAL EVALUATION OF SHORT STATURE
⢠Anthropometrics: Ht, Wt., HC, Arm span, U/L
segment ratio
⢠Dysmorphic features
⢠Nutritional status
⢠Thyroid gland
⢠Tanner staging for puberty development
⢠Neurological exam
- visual acuity and visual fields, nystagmus
- signs of hydrocephalus, focal signs
40
43. TALL STATURE
⢠Height more than 97th percentile of the normal for
age, or more than 2 SDs above the mean height for
that age, sex and reference population
⢠Most often constitutional
44
46. MANAGEMENT OF TALL STATURE
⢠Reassurance of the family and the patient in constitutional tall
stature. May be oestrogen if expected final height > 3SD
⢠Hypogonadism: Sex steroid
⢠Gigantism: excision of pituitary adenoma, somatostatin
analogues, pegvisomant or radiotherapy
⢠CAH: glucocorticoids and mineralocorticoid replacement
⢠Central precocious puberty: GnRH analogues
47